As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 1, 2008
by Catharine Paddock, PhD for Medical News Today:
New research from France suggests that men and women have different risks for mild cognitive impairment (MCI) and progression to dementia. The researchers suggest stroke is a primary risk factor for men, and depression for women.
The study is the work of Dr Karen Ritchie, of the Université de Montpellier and La Colombière Hospital in Montpellier, and colleagues, and is published online ahead of print today, 1st May, in the Journal of Neurology, Neurosurgery, and Psychiatry.
The researchers carried out a prospective community based study over four years of 6,892 men and women aged 65 and over living in three cities in France.
None of the participants had dementia when enrolled on the study (baseline), and they all underwent cognitive performance tests, clinical diagnosis for dementia, and evaluation of clinical and environmental risk factors at baseline, year 2, and year 4 of the study.
The results showed that:
The researchers concluded that: “Men and women have different risk profiles for both MCI and progression to dementia.”
They recommended that interventions should: “Focus principally on risk of stroke in men and depressive symptomatology and use of anticholinergic medication in women.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.